Hello! We are with Dr. Nikhil Munshi, a world-renowned multiple myeloma blood cancer expert. Dr. Munshi joins from Boston. We will discuss multiple myeloma, the second most common blood cancer.

Dr. Munshi is a Professor of Medicine at the Harvard Medical School and the Director of Basic and Correlative Science, and Associate Director of the Jerome Lipper Multiple Myeloma Center and Kraft Professor of Medicine at the Dana Farber Cancer Institute. Dr. Munshi is an attending physician at the Brigham and Women’s Hospital and the Boston VA Healthcare System, Harvard Medical School.

Dr. Munshi received his MD from the Maharaja Sayjirao University in India. He completed a Research Fellowship in Medical Oncology at the Johns Hopkins Oncology Center and a clinical fellowship in hematology/oncology at Indiana University Medical Center.

Professor Munshi has done pioneering research in the genetics of multiple myeloma. His breakthrough work directly led to the development of cutting-edge precision medicine therapies for multiple myeloma, such as immunotherapy, CAR-T therapy, as well as multiple small molecule- and biologics-based targeted therapy for multiple myeloma.

Professor Munshi is a founding member and current president of the International Myeloma Society. Professor Munshi has served as a co-chair of the National Steering Committee on Myeloma at the National Cancer Institute and as a member of the National Cancer Institute Clinical Trials and Translational Research Advisory Committee.

Dr. Munshi was awarded the most prestigious award in myeloma, the “Waldenström’s Award”, for the most Distinguished Lifetime Achievement in Myeloma Research, the Dr. B.C. Roy National Award by the president of India, Robert Kyle Award in 2021 and a lifetime achievement award from Association of VA Hematologists and Oncologists.

Professor Munshi published over 500 articles in peer-reviewed medical journals and authored multiple books and book chapters on multiple myeloma and other blood cancers.

Professor Munshi, hello and welcome!

Hello, it's my pleasure to be here. And thank you for your kind introduction.